» Articles » PMID: 35896979

Clinical Features and F-FDG PET/CT for Distinguishing of Malignant Lymphoma from Inflammatory Lymphadenopathy in HIV-infected Patients

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2022 Jul 27
PMID 35896979
Authors
Affiliations
Soon will be listed here.
Abstract

Background: It is vital to distinguish between inflammatory and malignant lymphadenopathy in human immunodeficiency virus (HIV) infected individuals. The purpose of our study was to differentiate the variations in the clinical characteristics of HIV patients, and apply F-FDG PET/CT parameters for distinguishing of malignant lymphoma and inflammatory lymphadenopathy in such patients.

Methods: This retrospective cross-sectional study included 59 consecutive HIV-infected patients who underwent whole-body F-FDG PET/CT. Of these patients, 37 had biopsy-proven HIV-associated lymphoma, and 22 with HIV-associated inflammatory lymphadenopathy were used as controls. The determined parameters were the maximum of standard uptake value (SUV), SUV of only lymph nodes (SUV), the most FDG-avid lesion-to-liver SUV ratio (SUR), laboratory examinations and demographics. The optimal cut-off of F-FDG PET/CT value was analyzed by receiver operating characteristic curve (ROC).

Results: Considering the clinical records, the Karnofsky Performance Status (KPS) scores in patients with inflammatory lymphadenopathy were obviously higher than those in patients with malignant lymphoma (P = 0.015), whereas lymphocyte counts and lactate dehydrogenase (LDH) were obviously lower (P = 0.014 and 0.010, respectively). For the F-FDG PET/CT imaging, extra-lymphatic lesions, especially digestive tract and Waldeyer's ring, occurred more frequently in malignant lymphoma than inflammatory lymphadenopathy. Furthermore, the SUR and SUV in malignant lymphoma were markedly higher than those in inflammatory lymphadenopathy (P = 0.000 and 0.000, respectively). The cut-off point of 3.1 for SUR had higher specificity (91.9%) and relatively reasonable sensitivity (68.2%) and the cut-off point of 8.0 for the SUV had high specificity (89.2%) and relatively reasonable sensitivity (63.6%).

Conclusion: Our study identified the distinctive characteristics of the clinical manifestations, the SUR, SUV and detectability of extra-lymphatic lesions on F-FDG PET, and thus provides a new basis for distinguishing of malignant lymphoma from inflammatory lymphadenopathy in HIV-infected patients.

Citing Articles

Recent advancements in F-FDG PET/CT for the diagnosis, staging, and treatment management of HIV-related lymphoma.

Jamalipour Soufi G, Hekmatnia A, Hekmatnia F, Zarei A, Shafieyoon S, Azizollahi S Am J Nucl Med Mol Imaging. 2024; 14(2):97-109.

PMID: 38737646 PMC: 11087295. DOI: 10.62347/QPAS5990.


Research to develop a diagnostic ultrasound nomogram to predict benign or malignant lymph nodes in HIV-infected patients.

Huang C, Shi X, Ma X, Liu J, Huang J, Deng L BMC Infect Dis. 2023; 23(1):459.

PMID: 37430187 PMC: 10332024. DOI: 10.1186/s12879-023-08419-1.


Clinical value of F-FDG PET/CT in the management of HIV-associated lymphoma.

Liu Q, Yang T, Chen X, Liu Y Front Oncol. 2023; 13:1117064.

PMID: 36776334 PMC: 9909962. DOI: 10.3389/fonc.2023.1117064.


Different Uptake of Ga-FAPI and F-FDG in Lymphadenopathy Caused by Angioimmunoblastic T-Cell Lymphoma in a Patient with Colon Cancer.

Wu M, Pan Q, Luo Y Diagnostics (Basel). 2022; 12(9).

PMID: 36140612 PMC: 9497719. DOI: 10.3390/diagnostics12092211.

References
1.
Hocke M, Menges M, Topalidis T, Dietrich C, Stallmach A . Contrast-enhanced endoscopic ultrasound in discrimination between benign and malignant mediastinal and abdominal lymph nodes. J Cancer Res Clin Oncol. 2007; 134(4):473-80. DOI: 10.1007/s00432-007-0309-7. View

2.
Bogoch I, Andrews J, Nagami E, Rivera A, Gandhi R, Stone D . Clinical predictors for the aetiology of peripheral lymphadenopathy in HIV-infected adults. HIV Med. 2012; 14(3):182-6. PMC: 3562378. DOI: 10.1111/j.1468-1293.2012.01035.x. View

3.
Wang Z, Zhang R, Liu L, Shen Y, Chen J, Qi T . Incidence and spectrum of infections among HIV/AIDS patients with lymphoma during chemotherapy. J Infect Chemother. 2021; 27(10):1459-1464. DOI: 10.1016/j.jiac.2021.06.012. View

4.
Glushko T, He L, McNamee W, Babu A, Simpson S . HIV Lymphadenopathy: Differential Diagnosis and Important Imaging Features. AJR Am J Roentgenol. 2020; 216(2):526-533. DOI: 10.2214/AJR.19.22334. View

5.
Lee S, Sung C, Lee H, Yoon H, Kim S, Oh J . Is F-FDG PET/CT useful for the differential diagnosis of solitary pulmonary nodules in patients with idiopathic pulmonary fibrosis?. Ann Nucl Med. 2018; 32(7):492-498. DOI: 10.1007/s12149-018-1273-9. View